The purpose of this study is to find out if it is practical (feasible) to give dose-dense CMF (cyclophosphamide, methotrexate, and fluorouracil) in two standar…

Adenocarcinoma of the BreastBreast CancerTriple Negative Breast Cancer

~Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT07768436

Phase 1

SHARON: Study of Metastatic Cancers in Patients Using Autologous Stems Cells and Potentiated Redox Cycling to Overcome Drug Resistance to Nitrogen Mustard Derivatives

The clinical trial is a phase 1, single-arm trial that will evaluate the safety of the investigational treatment on metastatic pancreatic cancer and metastatic…

Pancreatic Adenocarcinoma MetastaticBRCA1 MutationBRCA2 Mutation+17 more

~Estimated

~$10 – $8,750

General Oncology, Inc.

NCT04150042